Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects

Journal of Perinatal Medicine
Gyula TálosiSándor Túri


Prostaglandin E1 (PGE1) treatment can be life saving in patients suffering from ductus dependent congenital heart defect. We analyzed the indications and side-effects of PGE1 therapy over a five-year period. The purpose of the study was also to examine whether a change in serum electrolyte levels could be detected. Forty-nine patients were treated with PGE1 during this period. PGE1 treatment was indicated by ductus dependent systemic circulation in 16 cases, ductus dependent pulmonary circulation in 17 cases, transposition of the great arteries in 13 cases and pulmonary hypertension (persistent fetal circulation) in three cases. As early side-effects of the treatment, fever occurred in 27/49 cases while apnoea was observed in 15 patients. In a one-week-old neonate with coarctation of the aorta grade III intraventricular hemorrhage developed. A mild decrease of sodium, potassium and chloride levels and a slight shift of pH levels toward metabolic alkalosis could be detected after one day and one week of PGE1 treatment. Because of these side-effects of PGE1 patients should be monitored in an intensive care unit. According to our observations electrolyte levels may exhibit a slight decrease; however, in the case of a short-term th...Continue Reading


Dec 1, 1989·European Journal of Pediatrics·J P LanghendriesJ M Bertrand
Mar 1, 1973·Canadian Journal of Physiology and Pharmacology·F Coceani, P M Olley
May 1, 1983·Archives of Disease in Childhood·J Al-DahhanL Stimmler
Jan 1, 1980·The Journal of Pediatrics·R I ClymanM A Heymann
Sep 1, 1995·European Journal of Pediatrics·H H KramerO Krogmann
Mar 1, 1996·European Journal of Pediatrics·A K KalloghlianM M deMoor
Jan 1, 1993·Current Opinion in Cardiology·M Tynan, S Qureshi
Dec 6, 2000·Acta Paediatrica·B Hoch, M Bernhard
Feb 15, 2001·The Journal of Pediatrics·R Arav-BogerR E Willoughby
Aug 30, 2001·Pediatric Cardiology·L Hellström-WestasN Svenningsen

❮ Previous
Next ❯


Oct 15, 2008·Orphanet Journal of Rare Diseases·Paula Martins, Eduardo Castela
Jan 29, 2011·Journal of Perinatology : Official Journal of the California Perinatal Association·G HiremathS Aggarwal
Aug 30, 2013·Journal of Perinatology : Official Journal of the California Perinatal Association·Y Molgat-SeonO Jay
Aug 11, 2011·Korean journal of pediatrics·Sin Weon Yun
Jun 14, 2019·Pharmacological Reports : PR·Wesam BassiouniTahia Daabees
Dec 29, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Ming-Feng DongLexin Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.